Tammela TLJ - Search Results

1

Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.

Gao P, Xia JH, Sipeky C, Dong XM, Zhang Q, Yang Y, Zhang P, Cruz SP, Zhang K, Zhu J, Lee HM, Suleman S, Giannareas N, Liu S; PRACTICAL Consortium; Tammela TLJ, Auvinen A, Wang X, Huang Q, Wang L, Manninen A, Vaarala MH, Wang L, Schleutker J, Wei GH. Gao P, et al. Among authors: tammela tlj. Cell. 2018 Jul 26;174(3):576-589.e18. doi: 10.1016/j.cell.2018.06.003. Epub 2018 Jul 19. Cell. 2018. PMID: 30033361 Free PMC article.

2

Evidence for a prostate cancer susceptibility locus on the X chromosome.

Xu J, Meyers D, Freije D, Isaacs S, Wiley K, Nusskern D, Ewing C, Wilkens E, Bujnovszky P, Bova GS, Walsh P, Isaacs W, Schleutker J, Matikainen M, Tammela T, Visakorpi T, Kallioniemi OP, Berry R, Schaid D, French A, McDonnell S, Schroeder J, Blute M, Thibodeau S, Grönberg H, Emanuelsson M, Damber JE, Bergh A, Jonsson BA, Smith J, Bailey-Wilson J, Carpten J, Stephan D, Gillanders E, Amundson I, Kainu T, Freas-Lutz D, Baffoe-Bonnie A, Van Aucken A, Sood R, Collins F, Brownstein M, Trent J. Xu J, et al. Nat Genet. 1998 Oct;20(2):175-9. doi: 10.1038/2477. Nat Genet. 1998. PMID: 9771711

3

Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families.

Matikainen MP, Schleutker J, Mörsky P, Kallioniemi OP, Tammela TL. Matikainen MP, et al. Clin Cancer Res. 1999 Jun;5(6):1275-9. Clin Cancer Res. 1999. PMID: 10389909

4

[Why screen for prostate cancer in Finland?].

Auvinen A, Hakama M, Rannikko S, Stenman UH, Tammela T. Auvinen A, et al. Duodecim. 1996;112(14):1241-3. Duodecim. 1996. PMID: 10596093 Finnish. No abstract available.

5

Is the incidence of hypospadias increasing? Analysis of Finnish hospital discharge data 1970-1994.

Aho M, Koivisto AM, Tammela TL, Auvinen A. Aho M, et al. Environ Health Perspect. 2000 May;108(5):463-5. doi: 10.1289/ehp.00108463. Environ Health Perspect. 2000. PMID: 10811575 Free PMC article.

6

Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene.

Mononen N, Syrjäkoski K, Matikainen M, Tammela TL, Schleutker J, Kallioniemi OP, Trapman J, Koivisto PA. Mononen N, et al. Cancer Res. 2000 Nov 15;60(22):6479-81. Cancer Res. 2000. PMID: 11103816

7

Randomized screening trial for prostate cancer in Finland.

Hakama M, Aro J, Auvinen A, Juusela H, Määttänen L, Stenman UH, Tammela TL. Hakama M, et al. Eur Urol. 2001 Apr;39 Suppl 4:32. doi: 10.1159/000052581. Eur Urol. 2001. PMID: 11340285 Clinical Trial. No abstract available.

8

Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer.

Isola J, Auvinen A, Poutiainen M, Kakkola L, Järvinen TA, Määttänen L, Stenman UH, Tammela T, Hakama M, Visakorpi T. Isola J, et al. J Urol. 2001 May;165(5):1569-74. J Urol. 2001. PMID: 11342919 Clinical Trial.

9

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland.

Mononen N, Ikonen T, Syrjäkoski K, Matikainen M, Schleutker J, Tammela TL, Koivisto PA, Kallioniemi OP. Mononen N, et al. Br J Cancer. 2001 May 18;84(10):1344-7. doi: 10.1054/bjoc.2001.1789. Br J Cancer. 2001. PMID: 11355945 Free PMC article.

10

Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland.

Matikaine MP, Pukkala E, Schleutker J, Tammela TL, Koivisto P, Sankila R, Kallioniemi OP. Matikaine MP, et al. Cancer Causes Control. 2001 Apr;12(3):223-30. doi: 10.1023/a:1011283123610. Cancer Causes Control. 2001. PMID: 11405327

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

598 results

Search Page